On the public citation graph

Small Intestinal Bacterial Overgrowth Complicating Gastrointestinal Manifestations of Systemic Sclerosis: A Systematic Review and Meta-Analysis

https://doi.org/10.2139/ssrn.4074669
0 signed · 49 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/path.1711660307openalex-extracted
Sequential dermal microvascular and perivascular changes in the development of scleroderma
inferredcites →https://doi.org/10.1007/bf02090373openalex-extracted
Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis
inferredcites →https://doi.org/10.1007/s00535-017-1371-9openalex-extracted
Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth
inferredcites →https://doi.org/10.1007/s10067-020-05549-8openalex-extracted
Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1007/s10620-007-0065-1openalex-extracted
A Systematic Review of Diagnostic Tests for Small Intestinal Bacterial Overgrowth
inferredcites →https://doi.org/10.1007/s10620-009-0778-4openalex-extracted
Evaluating Breath Methane as a Diagnostic Test for Constipation-Predominant IBS
inferredcites →https://doi.org/10.1007/s10620-019-05830-0openalex-extracted
Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis
inferredcites →https://doi.org/10.1007/s10620-021-07149-1openalex-extracted
Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia
inferredcites →https://doi.org/10.1007/s11938-018-0207-xopenalex-extracted
Gastroduodenal “Dysbiosis”: a New Clinical Entity
inferredcites →https://doi.org/10.1007/s12664-020-01107-xopenalex-extracted
Basics of meta-analysis
inferredcites →https://doi.org/10.1007/s12664-021-01235-yopenalex-extracted
Small intestinal bacterial overgrowth in inflammatory bowel disease
inferredcites →https://doi.org/10.1016/0016-5085(80)90091-8openalex-extracted
The gastrointestinal manifestations of scleroderma: Pathogenesis and management
inferredcites →https://doi.org/10.1016/b978-0-323-54843-4.00006-4openalex-extracted
Clinical Conditions Associated With Bacterial Overgrowth
inferredcites →https://doi.org/10.1016/j.autrev.2015.01.018openalex-extracted
Fecal calprotectin in systemic sclerosis and review of the literature
inferredcites →https://doi.org/10.1016/j.dld.2008.01.017openalex-extracted
Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease
inferredcites →https://doi.org/10.1016/j.injr.2014.10.156openalex-extracted
Gastrointestinal manifestations of systemic sclerosis – clinical and investigative study of 50 patients
inferredcites →https://doi.org/10.1016/j.jpedsurg.2012.03.019openalex-extracted
Risk factors for small bowel bacterial overgrowth and diagnostic yield of duodenal aspirates in children with intestinal failure: a retrospective review
inferredcites →https://doi.org/10.1016/j.rdc.2017.09.002openalex-extracted
Gastrointestinal and Hepatic Disease in Systemic Sclerosis
inferredcites →https://doi.org/10.1016/j.semarthrit.2012.09.004openalex-extracted
Lactulose Breath Test to Assess Oro-cecal Transit Delay and Estimate Esophageal Dysmotility in Scleroderma Patients
inferredcites →https://doi.org/10.1016/s0140-6736(17)30933-9openalex-extracted
Systemic sclerosis
inferredcites →https://doi.org/10.1016/s0973-3698(10)60644-9openalex-extracted
P29 Gastrointestinal involvement in systemic sclerosis—a cross sectional study in Indian population
inferredcites →https://doi.org/10.1053/j.gastro.2005.11.061openalex-extracted
Functional Bowel Disorders
inferredcites →https://doi.org/10.1053/j.gastro.2016.02.011openalex-extracted
Gastroduodenal Disorders
inferredcites →https://doi.org/10.1056/nejm199111213252102openalex-extracted
Effect of Octreotide on Intestinal Motility and Bacterial Overgrowth in Scleroderma
inferredcites →https://doi.org/10.1080/19490976.2021.1933313openalex-extracted
Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1093/oxfordjournals.qjmed.a068958openalex-extracted
Ischaemia of the small intestine in patients with systemic sclerosis: Raynaud's phenomenon or chronic vasculopathy?
inferredcites →https://doi.org/10.1093/rheumatology/34.10.976openalex-extracted
EVIDENCE OF OMEPRAZOLE-INDUCED SMALL BOWEL BACTERIAL OVERGROWTH IN PATIENTS WITH SCLERODERMA
inferredcites →https://doi.org/10.1093/rheumatology/34.3.265openalex-extracted
SMALL BOWEL BACTERIAL OVERGROWTH IN SYSTEMIC SCLEROSIS: DETECTION USING DIRECT AND INDIRECT METHODS AND TREATMENT OUTCOME
inferredcites →https://doi.org/10.1093/rheumatology/kem329openalex-extracted
Home parenteral nutrition--an effective and safe long-term therapy for systemic sclerosis-related intestinal failure
inferredcites →https://doi.org/10.1093/rheumatology/kep226openalex-extracted
Small intestinal bacterial overgrowth in systemic sclerosis
inferredcites →https://doi.org/10.1093/rheumatology/kes429openalex-extracted
Gastrointestinal motility disorder assessment in systemic sclerosis
inferredcites →https://doi.org/10.1097/bor.0000000000000645openalex-extracted
Gastrointestinal involvement in systemic sclerosis: an update
inferredcites →https://doi.org/10.1097/xeb.0000000000000054openalex-extracted
Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data
inferredcites →https://doi.org/10.1111/1756-185x.13495openalex-extracted
Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients
inferredcites →https://doi.org/10.1111/apt.12456openalex-extracted
Review article: small intestinal bacterial overgrowth - prevalence, clinical features, current and developing diagnostic tests, and treatment
inferredcites →https://doi.org/10.1111/j.1365-2230.1980.tb01662.xopenalex-extracted
Small intestinal bacterial growth in systemic sclerosis
inferredcites →https://doi.org/10.1111/j.1365-2982.2011.01686.xopenalex-extracted
The role of small intestinal bacterial overgrowth in postgastrectomy patients
inferredcites →https://doi.org/10.1111/j.1572-0241.2007.01758.xopenalex-extracted
Small Intestinal Bacterial Overgrowth in Patients Suffering From Scleroderma: Clinical Effectiveness of Its Eradication
inferredcites →https://doi.org/10.1136/annrheumdis-2017-eular.6824openalex-extracted
AB0657 Small intestinal bacterial overgrowth in relation to gastrointestinal symptoms in systemic sclerosis
inferredcites →https://doi.org/10.1136/bmj.b2535openalex-extracted
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
inferredcites →https://doi.org/10.1136/gut.35.3_suppl.s11openalex-extracted
Octreotide in gastrointestinal motility disorders.
inferredcites →https://doi.org/10.1136/gut.45.2008.ii43openalex-extracted
Functional bowel disorders and functional abdominal pain
inferredcites →https://doi.org/10.1177/23971983211032808openalex-extracted
Fecal microbiome differs between patients with systemic sclerosis with and without small intestinal bacterial overgrowth
inferredcites →https://doi.org/10.1186/1471-230x-8-7openalex-extracted
Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma
inferredcites →https://doi.org/10.14309/ajg.0000000000000501openalex-extracted
ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth
inferredcites →https://doi.org/10.14309/ajg.0000000000000504openalex-extracted
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies
inferredcites →https://doi.org/10.17615/x3mq-ct28openalex-extracted
inferredcites →https://doi.org/10.3109/00365521.2011.603158openalex-extracted
Gastrointestinal transit in patients with systemic sclerosis
inferredcites →https://doi.org/10.3390/diagnostics10080587openalex-extracted
The Role of Fecal Calprotectin in Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth (SIBO)
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.